Regulatory tightening in UK M&A market ‘weeding out’ weaker distribution firms

Those keeping an eye on the UK insurance mergers and acquisitions (M&A) market may have noticed a slowdown in activity over the past few years.

And this perception is anything but anecdotal. Corporate advisory firm MarshBerry’s recent analysis, published 7 July 2026, revealed that broker and MGA M&A deal volumes have hit multi-year lows, with only 41 deals in H1 2026 making this the slowest market since 2017.

While the softening market is commonly cited as a source of friction to potential transactions, UK regulatory changes introduced over the past few years have stirred up greater uncertainty for insurance distributors – especially those operating at the SME and mid-market sizes.

Among the most significant regulatory changes were the FCA’s Consumer Duty, which came into force on July 2023 with an extension in July 2024 to encompass closed legacy products and services, and the regulator’s enhanced product intervention and product governance (Prod) rules, which were set in 2021 to explicitly require firms to assess and document the fair value of products.

In turn, the evolution and aggregation of compliance risks for those operating in the UK insurance M&A market has multiplied the hoops for firms to jump through, increasing due diligence requirements and extending deal timelines.

The resulting slowdown of activity was reflected in the Ideals M&A Outlook 2026, which revealed the average M&A transaction took 264 days to complete in 2025 – up from 205 days in 2020.

Speaking to Insurance Times, David Leslie, managing director at M&A consultancy firm Leslie James Acquisitions, believes that this regulatory tightening “has materially slowed consolidation in the UK insurance distribution sector while accelerating selective market exits”.

With fewer medium-sized transactions, as buyers demand stronger evidence of compliant customer outcomes, Leslie explained that “this selectivity favours well-prepared, specialist or high-quality targets, compressing valuations for those with legacy conduct weaknesses or scaling challenges”.

He added: “For many smaller or mid-tier firms, heightened compliance costs, operational resilience requirements and senior manager accountability have raised barriers to independent operation.

“This is prompting more exits via sale, particularly among owners facing soft market pressures or succession issues.”

An uncertain market

For Andrew Houghton, private equity partner at law firm Reed Smith, compliance risk has shifted from a discrete legal diligence tickbox to a core value driver in UK insurance M&A.

Houghton told Insurance Times that buyers are now focusing on earnings and retention as well as underwriting conduct, governance and business continuity with “similar intensity”.

In turn, he explained that brokers and MGAs are facing probing compliance questions on Consumer Duty, product governance, fair value, delegated authority oversight, appointed representative arrangements, claims and complaints, financial crime and data and cyber controls.

He continued: “An unprepared firm may still be a good business, but buyers will likely have to spend more time identifying and scoping gaps, planning remediation and pricing in the risk of regulatory scrutiny.

“In a competitive sale process, that can be the difference between a smooth auction and a drawn‑out process where value leaks.”

Despite this, Jamie Richards, head of M&A at MGA Ripe, told Insurance Times that the volume and complexity of regulatory requirements is making “unintentional non-compliance more common”.

This, Richards explained, coupled with a “pressure” on buyers to value target firms accurately in “uncertain pricing environments”, often “prolongs negotiation, deal slowdown and, in some cases, a full breakdown” of a transaction.

Meanwhile, complex deal structures are also playing a part in this deal friction, he said, as the industry is seeing an “increased use of escrows, earn-outs and warranty protections to manage perceived risks”.

He continued: “While these mechanisms can help facilitate transactions, they often place additional risk back onto sellers and can lengthen negotiations as parties work through risk allocation.

“In some cases, particularly where serious compliance breaches have occurred, such as issues relating to client money, transactions may fail altogether.”

Regulatory ‘weeding’

In an increasingly selective and capital-disciplined market, the value of regulatory preparedness for scrutiny in the deal process is indisputable.

With buyers looking for transparency and clear direction, Richards explained that “regulatory preparedness is increasingly becoming a key differentiator between assets of otherwise similar commercial quality”.

He added that the MGA is seeing an increasing number of firms “engage in pre-transaction regulatory health checks”.

“From experience, well-prepared assets are significantly less likely to face last-minute price reductions, escrow requirements or other deal protections designed to mitigate perceived regulatory risk,” he continued.

“As competition for high-quality insurance assets remains strong, firms are increasingly embedding regulatory considerations into their strategic planning well before a transaction is contemplated. Rather than viewing compliance as a pre-sale activity, businesses are investing in compliance infrastructure earlier in the process.”

Commonly sought advice from intermediaries on adherence to these rules, Leslie explained, includes that for enhanced regulatory due diligence and back-book reviews, robust integration plans demonstrating no consumer harm, change-in-control preparedness and early regulator engagement, as well as cultural and governance alignment and remediation strategies.

This could be particularly crucial as Leslie noted that current capital gains tax concerns – a tax on the profit made when selling an asset that has increased in value – could encourage sellers to advance transactions and spur M&A activity in the second half of the year.

“Regulation is reshaping the market toward greater concentration among resilient players, while weeding out weaker participants and encouraging earlier, compliance-driven exits,” he concluded.

“This dynamic supports long-term stability but reduces short-term deal flow and increases execution risk.”